We are live on ! Find out more
BCM

Boone Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 86.31%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+86.31%
3 Year Est. Return
+255.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$279M
AUM Growth
+$65M
Cap. Flow
+$41.9M
Cap. Flow %
15.04%
Top 10 Hldgs %
89.43%
Holding
13
New
1
Increased
7
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$14.5M
2
IDYA icon
IDEAYA Biosciences
IDYA
+$10.2M
3
DHR icon
Danaher
DHR
+$5.1M
4
ENOV icon
Enovis
ENOV
+$5.01M
5
MOH icon
Molina Healthcare
MOH
+$4.06M

Top Sells

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$1.07M

Sector Composition

Rank Sector Weight
1 Healthcare 85.32%
2 Financials 14.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNM icon
1
Unum
UNM
$13.6B
$40.9M 14.68%
857,565
– –
MOH icon
2
Molina Healthcare
MOH
$10.2B
$32.1M 11.52%
106,519
+14,107
+15% +$4.06M
BAX icon
3
Baxter International
BAX
$13.6B
$31.3M 11.25%
687,701
+333,258
+94% +$14.5M
CI icon
4
Cigna
CI
$74.8B
$31M 11.13%
110,551
+7,928
+8% +$2.06M
ENOV icon
5
Enovis
ENOV
$1.67B
$27.4M 9.85%
427,793
+88,035
+26% +$5.01M
DHR icon
6
Danaher
DHR
$137B
$26.4M 9.47%
123,978
+24,107
+24% +$5.1M
AMGN icon
7
Amgen
AMGN
$207B
$18.5M 6.65%
83,499
+4,349
+5% +$1.01M
BIIB icon
8
Biogen
BIIB
$30.3B
$17.9M 6.43%
62,877
+3,355
+6% +$999K
ABBV icon
9
AbbVie
ABBV
$450B
$11.9M 4.26%
88,026
– –
IDYA icon
10
IDEAYA Biosciences
IDYA
$3.43B
$11.7M 4.19%
+496,433
New +$10.2M
QTRX icon
11
Quanterix
QTRX
$161M
$11.3M 4.06%
501,144
-60,000
-11% -$1.07M
CERE
12
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$9.54M 3.42%
300,000
– –
TBRG
13
DELISTED
TruBridge
TBRG
$8.62M 3.1%
349,245
– –

Similar funds

ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
AFA
Alpha Financial Advisors Charlotte, North Carolina $326M AUM 15.49% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return
TC
TFR Capital Plano, Texas $326M AUM 24.24% 1-Year Est. Return

Boone Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boone Capital Management held 13 positions worth $279M, up 30% from $214M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Boone Capital Management deployed $41.9M of net new capital in Q2 2023, opening 1 new position and adding to 7 existing holdings. Its largest new stake was IDEAYA Biosciences: 496,433 shares worth $11.7M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 84% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Quanterix, an estimated $1.07M trimmed.

  • Boone Capital Management's largest Q2 2023 buy was IDEAYA Biosciences: 496,433 shares worth $11.7M.
  • Boone Capital Management added most to Baxter International in Q2 2023, an estimated $14.5M increase.
  • Boone Capital Management's biggest Q2 2023 reduction was Quanterix, cutting an estimated $1.07M.
  • Boone Capital Management's ten largest holdings make up 89% of its $279M portfolio in Q2 2023.
  • Boone Capital Management opened 1 new position and closed 0 in Q2 2023.
  • Boone Capital Management's portfolio value rose 30% quarter-over-quarter to $279M.

Based on Boone Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.